Trial Outcomes & Findings for Use of Transcranial Direct Current Stimulation (tDCS) Coupled With Constraint Induced Movement Therapy in Stroke Patient (NCT NCT01143649)
NCT ID: NCT01143649
Last Updated: 2020-04-24
Results Overview
Jebsen Taylor Hand Function Test: measures hand function in real-life activities, by evaluating the time required to perform 7 different tasks. We used the non-cronstrained hand for the assessments. The sum of the different tasks was used for the analysis.
COMPLETED
NA
44 participants
2 weeks
2020-04-24
Participant Flow
Participant milestones
| Measure |
tDCS + CIMT - Stroke
Participants will receive tDCS over the primary motor cortex (M1). We will use the following stimulation parameters: intensity of 1mA and for the first 40 minutes of constraint induced movement therapy (CIMT- 10 consecutive sessions Monday- Friday).
Transcranial Stimulation: Subjects will be stimulated at 1 mA for 40 minutes.
|
Sham tDCS + CIMT - Stroke
Participants will receive tDCS over the primary motor cortex (M1). We will use the following stimulation parameters: intensity of 1mA and for the first 40 minutes of constraint induced movement therapy (CIMT- 10 consecutive sessions Monday- Friday).
Sham stimulation consists of 30secondes of stimulation at the beginning of the 40minutes treatment.
|
Healthy Participants: Active tDCS + Motor Training
Each stimulation day will include up to six hours of training termed "shaping" in the non-dominant hand while the dominant hand is restrained in a resting hand splint and secured in a sling. At the start of this training, subjects will undergo 40 minutes of tDCS at 1mA.
|
Healthy Participants: Sham tDCS + Motor Training
Each stimulation day will include up to six hours of training termed "shaping" in the non-dominant hand while the dominant hand is restrained in a resting hand splint and secured in a sling. At the start of this training, subjects will undergo 40 minutes of sham tDCS.
|
Healthy Participants - Active tACS, Then Sham
Subjects will receive 20 min of active then sham tACS over the primary motor cortex in a randomized order.
|
Healthy Participants - Sham tACS, Then Active
Subjects will receive 20 min of sham and then tACS over the primary motor cortex in a randomized order.
|
|---|---|---|---|---|---|---|
|
Overall Study
STARTED
|
7
|
7
|
10
|
10
|
5
|
5
|
|
Overall Study
COMPLETED
|
7
|
7
|
10
|
10
|
4
|
3
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
0
|
0
|
1
|
2
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Use of Transcranial Direct Current Stimulation (tDCS) Coupled With Constraint Induced Movement Therapy in Stroke Patient
Baseline characteristics by cohort
| Measure |
tDCS + CIMT - Stroke
n=7 Participants
Participants received active tDCS over the primary motor cortex (M1). We used the following stimulation parameters: intensity of 1mA and for the first 40 minutes of constraint induced movement therapy (CIMT- 10 consecutive sessions Monday- Friday).
Transcranial Stimulation: Subjects were stimulated at 1 mA for 40 minutes.
|
Sham tDCS + CIMT - Stroke
n=7 Participants
Participants received sham tDCS over the primary motor cortex plus CIMT. The same site and parameters of stimulation were employed, but the stimulator was turned off after 30 seconds of stimulation. This ensured that patients could feel the initial itching sensation at the beginning of tDCS.
|
tDCS Active + CIMT - Healthy
n=10 Participants
Participants received active (1mA - 40min) of the primary motor cortex (M1) bilaterally combined with unilateral motor training and contralateral hand restraint.
|
Sham tDCS + CIMT - Healthy
n=10 Participants
Participants received sham tDCS (1mA - 40min) of the primary motor cortex (M1) bilaterally combined with unilateral motor training and contralateral hand restraint.
|
tACS Active&Sham - Healthy
n=10 Participants
active or sham 15Hz-tACS over of the primary motor cortex (M1) bilaterally.
|
Total
n=44 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
0 Participants
n=157 Participants
|
0 Participants
n=390 Participants
|
0 Participants
n=16 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
7 Participants
n=99 Participants
|
6 Participants
n=107 Participants
|
10 Participants
n=206 Participants
|
10 Participants
n=157 Participants
|
10 Participants
n=390 Participants
|
43 Participants
n=16 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=99 Participants
|
1 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
0 Participants
n=157 Participants
|
0 Participants
n=390 Participants
|
1 Participants
n=16 Participants
|
|
Age, Continuous
|
42.5 years
STANDARD_DEVIATION 12.8 • n=99 Participants
|
50.8 years
STANDARD_DEVIATION 14.9 • n=107 Participants
|
20.4 years
STANDARD_DEVIATION 1.7 • n=206 Participants
|
20.4 years
STANDARD_DEVIATION 1.7 • n=157 Participants
|
35.83 years
STANDARD_DEVIATION 18.65 • n=390 Participants
|
35.75 years
STANDARD_DEVIATION 11.69 • n=16 Participants
|
|
Sex: Female, Male
Female
|
4 Participants
n=99 Participants
|
5 Participants
n=107 Participants
|
7 Participants
n=206 Participants
|
7 Participants
n=157 Participants
|
4 Participants
n=390 Participants
|
27 Participants
n=16 Participants
|
|
Sex: Female, Male
Male
|
3 Participants
n=99 Participants
|
2 Participants
n=107 Participants
|
3 Participants
n=206 Participants
|
3 Participants
n=157 Participants
|
6 Participants
n=390 Participants
|
17 Participants
n=16 Participants
|
PRIMARY outcome
Timeframe: 2 weeksPopulation: The Jebsen Taylor Hand Function Test was only performed in the stroke study (Experiment 1).
Jebsen Taylor Hand Function Test: measures hand function in real-life activities, by evaluating the time required to perform 7 different tasks. We used the non-cronstrained hand for the assessments. The sum of the different tasks was used for the analysis.
Outcome measures
| Measure |
tDCS + CIMT
n=7 Participants
Participants will receive tDCS over the primary motor cortex (M1). We will use the following stimulation parameters: intensity of 1mA and for the first 40 minutes of constraint induced movement therapy (CIMT- 10 consecutive sessions Monday- Friday).
Transcranial Stimulation: Subjects will be stimulated at 1 mA for 40 minutes.
|
Sham tDCS + CIMT
n=7 Participants
Participants received sham tDCS over the primary motor cortex plus CIMT. The same site and parameters of stimulation were employed, but the stimulator was turned off after 30 seconds of stimulation. This ensured that patients could feel the initial itching sensation at the beginning of tDCS.
|
|---|---|---|
|
Jebsen Taylor Hand Function Test
|
68 seconds
Standard Error 34
|
80 seconds
Standard Error 42
|
PRIMARY outcome
Timeframe: 1 hourPopulation: The cortical excitability measurement (MEP) was performed in healthy participants involved in the tDCS+CIMT study (Experiment 2).
Motor evoked potential (MEP) Using Transcranial Magnetic Stimulation (TMS), MEP were recorded before and after tDCS (both active and sham). The percentage of change in MEP (post versus pre intervention) between the two groups (active and sham) were used for the comparison.
Outcome measures
| Measure |
tDCS + CIMT
n=20 Participants
Participants will receive tDCS over the primary motor cortex (M1). We will use the following stimulation parameters: intensity of 1mA and for the first 40 minutes of constraint induced movement therapy (CIMT- 10 consecutive sessions Monday- Friday).
Transcranial Stimulation: Subjects will be stimulated at 1 mA for 40 minutes.
|
Sham tDCS + CIMT
n=20 Participants
Participants received sham tDCS over the primary motor cortex plus CIMT. The same site and parameters of stimulation were employed, but the stimulator was turned off after 30 seconds of stimulation. This ensured that patients could feel the initial itching sensation at the beginning of tDCS.
|
|---|---|---|
|
Cortical Excitability
|
19.8 percent change
Standard Deviation 21.4
|
0.8 percent change
Standard Deviation 8.3
|
PRIMARY outcome
Timeframe: 15 minutesPopulation: The brain oscillations measurements were only performed in the tACS study (Experiment 3).
Recording took place in a dim-lighted room set up with acoustic and electric isolation. EEG was acquired from 64-channels HydroCel Geodesic Sensor Net (Electrical Geodesic Inc., Eugene, OH) and recorded using Net Station running on a MacIntosh G4 computer. Alpha power were used as the main outcome measure. The difference values (e.g., post minus pre tACS) were used for the analysis. The alpha frequency is a brain oscillation that takes place especially when subjects are in a relaxed state, especially eyes closed. In the motor cortex, a decrease in alpha power has been seen during motor performance. Therefore, it could be speculated that a decrease in power in this study would indicate more engagement in motor cortex during the motor performance.
Outcome measures
| Measure |
tDCS + CIMT
n=7 Participants
Participants will receive tDCS over the primary motor cortex (M1). We will use the following stimulation parameters: intensity of 1mA and for the first 40 minutes of constraint induced movement therapy (CIMT- 10 consecutive sessions Monday- Friday).
Transcranial Stimulation: Subjects will be stimulated at 1 mA for 40 minutes.
|
Sham tDCS + CIMT
n=7 Participants
Participants received sham tDCS over the primary motor cortex plus CIMT. The same site and parameters of stimulation were employed, but the stimulator was turned off after 30 seconds of stimulation. This ensured that patients could feel the initial itching sensation at the beginning of tDCS.
|
|---|---|---|
|
Cortical Oscillations - EEG
|
-0.03 microVolt^2
Standard Deviation 0.24
|
0.07 microVolt^2
Standard Deviation 0.16
|
Adverse Events
tDCS + CIMT - Stroke
Sham tDCS + CIMT - Stroke
Active tDCS + CIMT - Healthy
Sham tDCS + CIMT - Healthy
Active tACS - Healthy
Sham tACS - Healthy
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr. Felipe Fregni
Laboratory of Neuromodulation and Center of Clinical Research Training. Spaulding Rehabilitation Hospital.
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place